Meta-analysis of 9 studies (1279 patients) of head and neck cancer chemoradiotherapy: prophylactic vs reactive PEG showed no significant difference in tube dependence (6 months OR 1.15) or survival; hospitalisation, synthesised narratively, was lower with prophylactic PEG.
Meta-analysisn = 1,279
Alqutub et al. Prophylactic vs. reactive percutaneous endoscopic gastrostomy (PEG) tubes in head and neck cancer: a meta-analysis of survival and supportive care outcomes